Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-19-053661

Director acquired 218,400 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Frueh Klaus · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-10-16 Conversion : show line 1 in the form +218,400 362,844 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-10-16 Conversion : show line 2 in the form Series A-2 Convertible Preferred Stock −218,400 0 I
Loading xslF345X03/doc4.xml…